Form 4 for NBIX NEUROCRINE BIOSCIENCES INC
Accepted 2025-12-17 00:00:00 ET · period of report 2025-12-15 · accession 0001533568-25-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-12-17 | 2025-12-15+ | NBIX | Norwalk Leslie V | Dir | S - Sale+OE | $152.78 | -6,190 | 6,239 | -50% | -$945.7K |
| DM | 2025-12-17 | 2025-12-15 | NBIX | Norwalk Leslie V | Dir | M - OptEx | $91.07 | +10.0K | 10.7K | +1,418% | +$910.7K |
| DM | 2025-12-17 | 2025-12-15 | NBIX | Norwalk Leslie V | Dir | M - OptEx | $0.00 | -10.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-15 | S | D | 5,000 | $152.23 | 7,429 | D | — | — | (F2) Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $151.79 to $152.82. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| 2 | Common | Common Stock | 2025-12-15 | M | A | 1,724 | $84.95 | 12,429 | D | — | — | |
| 3 | Common | Common Stock | 2025-12-15 | M | A | 8,276 | $92.35 | 10,705 | D | — | — | |
| 4 | Common | Common Stock | 2025-12-16 | S | D | 1,190 | $155.09 | 6,239 | D | — | — | (F3) Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $155.09 to $155.40. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| 5 | Derivative | Non-Qualified Stock Option | 2025-12-15 | M | D | 8,276 | $0.00 | 557 | D | $92.35 · — to 2031-05-19 | 8,276 Common Stock | (F4) The option was granted on May 19, 2021 and vested in 12 equal monthly installments beginning June 19, 2021. |
| 6 | Derivative | Non-Qualified Stock Option | 2025-12-15 | M | D | 1,724 | $0.00 | 0 | D | $84.95 · — to 2032-05-18 | 1,724 Common Stock | (F5) The option was granted on May 18, 2022 and vested in 12 equal monthly installments beginning June 18, 2022. |